DASH vs VIR · P/E 76, rev $13.72B vs rev $74.2M
DoorDash, Inc. Class A Common Stock (DASH) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. VIR currently screens at market cap $1.45B.
Not investment advice. Open the DASH and VIR stock pages for the full models.
Not investment advice.